Serum Interleukin-18 Levels Are Increased and ... - Diabetes Care

1 downloads 0 Views 55KB Size Report
13.1, P 0.0005), suggesting that hyper- glycemia per se ... icine, Osaka, Japan; and the 2Department of Internal Medicine, Osaka Police Hospital, Osaka, Japan.
Pathophysiology/Complications B R I E F

R E P O R T

Serum Interleukin-18 Levels Are Increased and Closely Associated With Various Soluble Adhesion Molecule Levels in Type 1 Diabetic Patients NAOTO KATAKAMI, MD, PHD1 HIDEAKI KANETO, MD, PHD1 MUNEHIDE MATSUHISA, MD, PHD1 KAZUTOMI YOSHIUCHI, MD1 KEN KATO, MD1

KAORU YAMAMOTO, MD1 YUTAKA UMAYAHARA, MD, PHD2 KEISUKE KOSUGI, MD, PHD2 MASATSUGU HORI, MD, PHD1 YOSHIMITSU YAMASAKI, MD, PHD1

R

RESEARCH DESIGN AND METHODS — A total of 77 Japanese type 1 diabetic patients (25 men and 52 women, mean ⫾ SD age 23.3 ⫾ 4.4 years, duration of diabetes 13.2 ⫾ 6.3 years, and daily urine C-peptide 5.2 ⫾ 8.8 ␮g/day) undergoing periodic follow-up examinations at the Diabetes Clinic of Osaka University Hospital and the Osaka Police Hospital were enrolled. All patients were treated with insulin alone and performed at least three or four daily insulin injections. The daily insulin dose was 0.88 ⫾ 0.25 U/kg. Urinary albumin excretion was 16.4 ⫾ 40.7 mg/day; 17 patients had simple diabetic retinopathy, and 4 had proliferative retinopathy. As control subjects, we enrolled 22 age-matched healthy nondiabetic individuals (11 men and 11 women aged 25.0 ⫾ 2.5 years). None of the subjects had any clinical evidence of infection, connective tissue disease, liver dysfunction, or cardiovascular diseases. None of the subjects were taking any oral hypoglycemic drugs or antihypertensive, antiplatelet, or lipid-lowering medication. After a full explanation of the study, written informed consent was obtained from each subject. The study was approved by the Ethical Committee for

ecent studies have shown that low-grade inflammation plays an important role in the development of diabetes vascular complications (1). Interleukin-18 (IL-18) is well known to play a key role in various inflammatory and autoimmune diseases (2). IL-18 produces proinflammatory cytokines and upregulates various adhesion molecule expression (3,4). These processes could lead to the development of diabetes vascular complications including atherosclerosis. Indeed, serum IL-18 levels can be a strong predictor of death in patients with cardiovascular diseases (5,6) and is associated with nephropathy and atherosclerosis in type 2 diabetic patients (7). It was also reported (8) that serum IL-18 levels were increased during the early developing stage of type 1 diabetes, but we cannot exclude the possibility that these results were simply influenced by inflammation at the onset of type 1 diabetes. In this study, we examined serum IL-18 levels in the chronic stage of type 1 diabetes and the possible association between serum IL-18 and various soluble adhesion molecule levels.

● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●

From the 1Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan; and the 2Department of Internal Medicine, Osaka Police Hospital, Osaka, Japan. Address correspondence and reprint requests to Naoto Katakami, Department of Internal Medicine and Therapeutics (A8), Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail: [email protected]. Received for publication 21 August 2006 and accepted in revised form 7 October 2006. Abbreviations: hs-CRP, high-sensitivity C-reactive protein; IL, interleukin; sE-selectin, soluble Eselectin; sICAM-1, soluble intracellular adhesion molecule-1; sVCAM-1, soluble vascular cell adhesion molecule-1. A table elsewhere in this issue shows conventional and Syste`me International (SI) units and conversion factors for many substances. DOI: 10.2337/dc06-1768 © 2007 by the American Diabetes Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

DIABETES CARE, VOLUME 30, NUMBER 1, JANUARY 2007

Human Studies at Osaka University Graduate School of Medicine. Fasting serum total cholesterol and HDL cholesterol, triglyceride, A1C, highsensitivity C-reactive protein (hs-CRP), soluble intracellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), and soluble Eselectin (sE-selectin) levels were measured by SRL (Tokyo, Japan). To measure serum IL-18 levels, we used an enzymelinked immunosorbent assay (MBL, Nagoya, Japan). Data between two groups were compared by two-tailed unpaired Student’s t test, ␹2 test, or Mann-Whitney U test. Single linear univariate correlations and forward and backward stepwise multivariate regression analyses (F value for the inclusion and exclusion of variables was set at 4.0) were performed to evaluate the relationship between IL-18 and the variables listed in Table 1. Statistical significance was defined as a P value ⬍0.01. RESULTS — Clinical characteristics of the study subjects are presented in Table 1. A1C, hs-CRP levels, sICAM-1, sVCAM-1, and sE-selectin levels were significantly higher in type 1 diabetic patients compared with nondiabetic subjects (P ⬍ 0.01), as previously reported (9 –11). There was no significant difference between the two groups regarding the other clinical parameters. Serum IL-18 levels were significantly higher in type 1 diabetic subjects compared with nondiabetic subjects (192 ⫾ 80 vs. 122 ⫾ 69 ng/ml, P ⫽ 0.0005) and were closely associated with A1C levels (r ⫽ 0.351, P ⫽ 0.0005). Furthermore, a stepwise multivariate regression analysis demonstrated that A1C was an independent risk factor for a high IL-18 value (F ⫽ 13.1, P ⫽ 0.0005), suggesting that hyperglycemia per se influences IL-18 levels. Similarly, serum hs-CRP, sICAM-1, sVCAM-1, and sE-selectin levels were positively associated with A1C levels (data not shown). There was no statistically signif159

IL-18 in type 1 diabetes Table 1—Characteristics of the study subjects

n Sex (male/female) Age (years) Duration of diabetes (years) Smoking (yes/no) BMI (kg/m2) Systolic BP (mmHg) Diastolic BP (mmHg) A1C (%) Total cholesterol (mmol/l) HDL cholesterol (mmol/l) Triglyceride (mmol/l) hs-CRP (mg/l) sICAM-1 (ng/ml) sVCAM-1 (ng/ml) sE-selectin (ng/ml) IL-18 (ng/ml) Microalbuminuria (yes/no) Urinary albumin excretion (mg/day) Retinopathy (NDR/SDR/PDR)

Control subjects

Type 1 diabetic subjects

22 11/11 25.0 ⫾ 2.5 — 3/19 20.6 ⫾ 1.9 113 ⫾ 11 66 ⫾ 8 4.6 ⫾ 0.3 4.66 ⫾ 0.73 1.68 ⫾ 0.34 0.81 ⫾ 0.31 0.223 ⫾ 0.225 166 ⫾ 72 499 ⫾ 200 30 ⫾ 10 122 ⫾ 69 — — —

77 25/52 23.3 ⫾ 4.4 13.2 ⫾ 6.3 9/68 21.4 ⫾ 1.8 116 ⫾ 13 71 ⫾ 9 7.8 ⫾ 1.5 4.87 ⫾ 0.80 1.86 ⫾ 0.36 1.08 ⫾ 0.68 0.977 ⫾ 1.799 215 ⫾ 63 630 ⫾ 142 46 ⫾ 22 192 ⫾ 80 63/6 16.2 ⫾ 43.8 55/17/4

P value 4. NS — NS* NS NS NS ⬍0.0001 NS NS NS 0.0081† 0.0025 0.0008 0.0009 0.0005 — — —

Data are means ⫾ SD. Student’s t test was performed. *␹2 test. †Mann-Whitney U test. BP, blood pressure; NDR, no diabetic retinopathy; PDR, proliferative diabetic retinopathy; SDR, simple diabetic retinopathy.

icant association between IL-18 levels and the duration of diabetes. Serum IL-18 levels were also closely associated with various soluble adhesion molecule levels such as sICAM-1 (r ⫽ 0.313, P ⫽ 0.0019) and sE-selectin levels (r ⫽ 0.451, P ⬍ 0.0001), although there was no correlation between IL-18 and sVCAM-1 levels (data not shown). Furthermore, a stepwise multivariate regression analysis demonstrated that IL-18 levels were an independent risk factor for a high sE-selectin value (F ⫽ 14.1). These results suggest that serum IL-18 levels influence various soluble adhesion molecule levels, although there was no significant association between serum IL-18 levels and diabetic retinopathy or nephropathy (data not shown).

shown that such adhesion molecule expression in endothelium leads to vascular dysfunction (12,13) and that increased soluble adhesion molecule levels in type 1 diabetic patients are related to the progression of diabetic vascular complications (14 –16). Therefore, increased IL-18 levels might be, at least in part, involved in the development of diabetic vascular complications, although we failed to detect a significant association between serum IL-18 levels and the severity of diabetic microangiopathy. A prospective study with a larger number of subjects would be necessary to prove whether diabetic patients with higher circulating IL-18 levels are more susceptible to diabetic vascular diseases.

CONCLUSIONS — In this study, we found that circulating IL-18 levels were significantly higher in type 1 diabetic subjects and that IL-18 levels were positively correlated with A1C levels. Furthermore, A1C levels were an independent determinant of IL-18 levels, suggesting that hyperglycemia itself affects IL-18 levels. Serum IL-18 levels were also closely associated with serum levels of several soluble adhesion molecules such as sICAM-1 and sE-selectin. It has been

References 1. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067– 2072, 2002 2. McInnes IB, Gracie JA, Leung BP, Wei XQ, Liew FY: Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 21:312–315, 2000 3. Dai SM, Matsuno H, Nakamura H, Nish-

160

5.

6. 7.

8.

9.

10.

11.

12.

13.

ioka K, Yudoh K: Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1 beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum 50:432– 443, 2004 Stuyt RJ, Netea MG, Geijtenbeek TB, Kullberg BJ, Dinarello CA, van der Meer JW: Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes. Immunology 110:329 –334, 2003 Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ: Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106:24 –30, 2002 Zaremba J, Losy J: Interleukin-18 in acute ischaemic stroke patients. Neurol Sci 24: 117–124, 2003 Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H: Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 28:2890 –2895, 2005 Nicoletti F, Conget I, DiMarco R, Speciale AM, Morinigo R, Bendtzen K, Gomis R: Serum levels of the interferon-gammainducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia 44:309 –311, 2001 Schalkwijk CG, Poland DC, van Dijk W, Kok A, Emeis JJ, Drager AM, Doni A, van Hinsbergh VW, Stehouwer CD: Plasma concentration of C-reactive protein is increased in type 1 diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 42:351–357, 1999 Schram MT, Chauturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, Stehouwer CD, the EURODIAB Prospective Complications Study: Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 26:2165–2173, 2003 Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G: Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med 22:999 –1004, 2005 Adams DH, Shaw S: Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343:831– 836, 1994 Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:

DIABETES CARE, VOLUME 30, NUMBER 1, JANUARY 2007

Katakami and Associates 301–314, 1994 14. Clausen P, Jacobsent T, Rossing K, Jensen JS, Parbing HH, Feldt-Rasmussen B: Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet Med

DIABETES CARE, VOLUME 30, NUMBER 1, JANUARY 2007

17:644 – 649, 2000 15. Fasching P, Veitl M, Rohac M, Streli C, Schneider B, Waldhausl W, Wagner OF: Elevated concentrations of circulating adhesion molecules and their aasociation with microvascular complications in insulin-dependent diabetes mellitus. J Clin

Endocrinol Metab 81:4313– 4317, 1996 16. Olson JA, Whitelaw CM, McHardy KC, Pearson DW, Forrester JV: Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia 40: 1166 –1171, 1997

161